Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-25

Clinical Trial Update: The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Asacol (mesalazine) suppository for diarrhea-induced acute fissure; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asacol (mesalamine)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Fissure in Ano, Diarrhea | Phase 1, Phase 2 | Status: COMPLETED